JP2010528644A5 - - Google Patents

Download PDF

Info

Publication number
JP2010528644A5
JP2010528644A5 JP2010510871A JP2010510871A JP2010528644A5 JP 2010528644 A5 JP2010528644 A5 JP 2010528644A5 JP 2010510871 A JP2010510871 A JP 2010510871A JP 2010510871 A JP2010510871 A JP 2010510871A JP 2010528644 A5 JP2010528644 A5 JP 2010528644A5
Authority
JP
Japan
Prior art keywords
human
tissue
dna sequence
cell according
human animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010510871A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010528644A (ja
Filing date
Publication date
Priority claimed from US11/757,972 external-priority patent/US7759541B2/en
Application filed filed Critical
Publication of JP2010528644A publication Critical patent/JP2010528644A/ja
Publication of JP2010528644A5 publication Critical patent/JP2010528644A5/ja
Pending legal-status Critical Current

Links

JP2010510871A 2007-06-04 2008-06-04 薬物の代謝及び毒性を評価するためのトランスジェニック動物 Pending JP2010528644A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/757,972 US7759541B2 (en) 2004-12-13 2007-06-04 Transgenic animals for assessing drug metabolism and toxicity
PCT/GB2008/001897 WO2008149080A1 (en) 2007-06-04 2008-06-04 Transgenic animals for assessing drug metabolism and toxicity

Publications (2)

Publication Number Publication Date
JP2010528644A JP2010528644A (ja) 2010-08-26
JP2010528644A5 true JP2010528644A5 (enExample) 2011-07-14

Family

ID=39698732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010510871A Pending JP2010528644A (ja) 2007-06-04 2008-06-04 薬物の代謝及び毒性を評価するためのトランスジェニック動物

Country Status (8)

Country Link
US (3) US7759541B2 (enExample)
EP (1) EP2173160A1 (enExample)
JP (1) JP2010528644A (enExample)
AU (1) AU2008259618A1 (enExample)
CA (1) CA2688438A1 (enExample)
IL (1) IL202127A0 (enExample)
IN (1) IN2009DN07390A (enExample)
WO (1) WO2008149080A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
AU2008322038B2 (en) * 2007-11-14 2012-02-23 National University Corporation Tottori University Mammalian artificial chromosome vector comprising human cytochrome P450 gene (cluster) and non-human mammalian animal retaining the same
EP4049535B1 (en) 2009-10-06 2024-11-27 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
WO2011160573A1 (zh) * 2010-06-21 2011-12-29 中国科学院上海生命科学研究院 一种生产高活性和高纯度利福霉素sv的方法
US20120023599A1 (en) * 2010-07-23 2012-01-26 Sigma-Aldrich Co. Genome editing of cytochrome p450 in animals
RU2730643C2 (ru) 2011-02-15 2020-08-24 Ридженерон Фармасьютикалз, Инк. Гуманизированные m-csf мыши
FR2979453B1 (fr) * 2011-08-26 2016-01-08 Olea Medical Systeme et procede pour estimer une quantite d'interet d'un systeme dynamique artere/tissu/veine
ES2624605T3 (es) * 2011-10-28 2017-07-17 Regeneron Pharmaceuticals, Inc. IL-6 y receptor de IL-6 humanizados
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
JP6283031B2 (ja) 2012-09-07 2018-02-21 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法
EP3308641B1 (en) * 2012-11-05 2019-07-03 Regeneron Pharmaceuticals, Inc. Immunodeficient, genetically modified rodent and methods of use thereof
US20140273031A1 (en) * 2013-03-15 2014-09-18 The Cleveland Clinic Foundation In-vitro method for monoclonal antibody production
HRP20170380T1 (hr) 2013-10-15 2017-05-19 Regeneron Pharmaceuticals, Inc. Životinje s humaniziranim il-5
ES2700972T3 (es) * 2013-11-19 2019-02-20 Regeneron Pharma Animales no humanos que tienen un gen de factor activador de células B humanizado
CA2929774C (en) * 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animal cells having a humanized proliferation-inducing ligand gene
US9665718B2 (en) 2014-03-14 2017-05-30 International Business Machines Corporation Correlating a task with commands to perform a change ticket in an IT system
CA2947309A1 (en) 2014-05-19 2015-11-26 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals expressing human epo
ES2950399T3 (es) 2015-04-13 2023-10-09 Regeneron Pharma Ratones humanizados Sirpa-IL15 insertados y métodos de uso de los mismos
JP2019524077A (ja) 2016-06-27 2019-09-05 ベイラー カレッジ オブ メディスンBaylor College Of Medicine P450オキシドレダクターゼ欠損を有するヒト肝臓キメラ非ヒト動物およびそれを使用する方法
CN109182292B (zh) * 2018-09-25 2022-02-08 安徽农业大学 一种草莓谷胱甘肽转移酶FaGST基因及其表达蛋白和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6476000A (en) 1999-08-13 2001-03-13 Kirin Beer Kabushiki Kaisha Mouse having human cytochrome p450 transferred therein
EP1088900A1 (en) 1999-09-10 2001-04-04 Epidauros Biotechnologie AG Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications
AU2002213660A1 (en) 2000-11-01 2002-05-15 The University Of Sydney Transgenic animals for analysing CYP3A4 cytochrome P450 gene regulation
AUPR446701A0 (en) 2001-04-18 2001-05-17 Gene Stream Pty Ltd Transgenic mammals for pharmacological and toxicological studies
JP2003304896A (ja) 2002-04-15 2003-10-28 Yasushi Yamazoe ヒトcyp3a誘導能の測定法
GB0216203D0 (en) 2002-07-12 2002-08-21 Imp Cancer Res Tech Mondulation of cytochrome P450 reductase activity
WO2004022738A1 (en) 2002-09-09 2004-03-18 California Institute Of Technology Methods and compositions for the generation of humanized mice
WO2006064197A2 (en) 2004-12-13 2006-06-22 Iti Scotland Limited Transgenic animals for assessing drug metabolism and toxicity
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity

Similar Documents

Publication Publication Date Title
JP2010528644A5 (enExample)
MacKenzie et al. Regulation of UDP glucuronosyltransferase genes
WO2018001241A1 (zh) 一种pd-1基因修饰人源化动物模型的构建方法及其应用
Scheer et al. Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications
Brady et al. A Novel Putative Transporter Maps to the Osteosclerosis (oc) Mutation and Is Not Expressed in theocMutant Mouse
JP2011501652A5 (enExample)
JP2015523863A5 (enExample)
JP7702140B2 (ja) P450オキシドレダクターゼ欠損を有するヒト肝臓キメラ非ヒト動物およびそれを使用する方法
ES2384760T3 (es) Deleción de un grupo de genes y humanización en dos etapas
WO2014028509A2 (en) Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
Tchekneva et al. Single amino acid substitution in aquaporin 11 causes renal failure
Kamimura Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations
EP2215240B1 (en) Knockout mice for a p450 gene cluster
Gonzalez Cytochrome P450 humanised mice
Shen et al. Humanized transgenic mouse models for drug metabolism and pharmacokinetic research
Katoh et al. Comparative integromics on FZD7 orthologs: conserved binding sites for PU. 1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5'-promoter region of mammalian FZD7 orthologs
JP5883265B2 (ja) ヒト肝細胞を担持するキメラ非ヒト動物
Zhou et al. CYP2D1 gene knockout reduces the metabolism and efficacy of venlafaxine in rats
KR101720099B1 (ko) 당뇨병 동물 모델 및 그 제조방법
Yasui et al. Molecular characterization of striated muscle-specific Gab1 isoform as a critical signal transducer for neuregulin-1/ErbB signaling in cardiomyocytes
NZ765428B2 (en) Non-human animals having a humanized programmed cell death 1 gene
Ming et al. Gene Polymorphisms of Immunosuppressants in Solid Organ Transplantation
王惠亮 et al. Molecular cloning and sequencing of heavy and light chain cDNAs from Papaya ringspot and Cymbidium mosaic viruses-specific monoclonal antibodies
CN101060855A (zh) 胃肠增殖因子及其用途
Baisiwala et al. TMOD-33. Single-cell atlas of pediatric brain tumors reveals targetable radial glia signatures in ependymoma